Categoría: News
-
Athersys May Get Up To $111M from Pfizer In Stem-Cell Deal
Pfizer signed a deal worth $111 million with Athersys involving development of the MultiStem product in the area of inflammatory bowel disease.
-
Stem-Cell Activators Switch Function, Repress Mature Cells
Because of their central role, the proteins could offer a safe and novel therapeutic target in many cancers. The proteins that arrest the multiplication of the cell may be considered as tumor suppressor proteins.
-
Effort to Regenerate Injured Spinal Cords Turns to a New Model
University of Florida McKnight Brain Institute received a $2.4 million National Institutes of Health grant to study regenerative process of the Mexican axolotl salamander with the aim of applying biological lessons learned to spinal cord injury.
-
Stem Cell Therapy Aids the Return of Lava Man
After 17 months Lava Man is scheduled to make a come-back this Saturday at Hollywood Park in the Native Diver Handicap. The horse was treated with his own fat derived stem cells by Dr. Doug Herthel.
-
TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology Meeting
The ability of TG-0054 to cause mobilization of EPC may support its use in other areas besides hematology. For instance the body may be able to grow new blood vessels around the areas of ischemia.
-
Brain tumor radiation resistance defeated
Dr. Jialiang Wang of Duke University reported that Notch signaling in tumor tissue is related to the failure of radiation treatments.
-
Sickle-cell disease can be cured with stem-cell transplant procedure
The New England Journal of Medicine reported a clinical trial at the Clinical Center of the National Institutes of Health in Bethesda, that described successful treatment of 9 out of 10 adults suffering from Sickle cell anemia.
-
Stem cells may hold the key to the fight against HIV
From the medical journal PloS ONE, scientists from the University of California Los Angeles reported that human blood cells derived from adult stem cells can be engineered into cells that can target and kill HIV-infected cells.
-
Stem Cell Derived Neurons for Research Relevant to Alzheimer’s and Niemann-Pick Type C Diseases
Stem cells were created from the skin of patients with these diseases and then the stem cells were made into disease-specific neurons by treatment with growth factors.
-
Human Umbilical Stem Cells Cleared Mice’s Cloudy Eyes
Researchers presented data indicating that treatment of mice that suffer from corneal scarring with stem cells derived from human umbilical cords leads to preservation of vision.